Hide metadata

dc.date.accessioned2019-12-04T19:12:59Z
dc.date.available2019-12-04T19:12:59Z
dc.date.created2019-01-11T16:05:25Z
dc.date.issued2018
dc.identifier.citationChee, Yuemin Celina Pahnke, Jens Bunte, Ralph Adsool, Vikrant A Madan, Babita Virshup, David M . Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche. Developmental Cell. 2018, 46(6), 681-695.e5
dc.identifier.urihttp://hdl.handle.net/10852/71163
dc.description.abstractThe gut absorbs dietary nutrients and provides a barrier to xenobiotics and microbiome metabolites. To cope with toxin exposures, the intestinal epithelium is one of the most rapidly proliferating tissues in the body. The stem cell niche supplies essential signaling factors including Wnt proteins secreted by subepithelial myofibroblasts. Unexpectedly, therapeutically effective doses of orally administered PORCN inhibitors that block all Wnt secretion do not affect intestinal homeostasis. We find that intestinal myofibroblasts are intrinsically resistant to multiple xenobiotics, including PORCN inhibitors and the anthracycline antibiotic doxorubicin. These myofibroblasts have high expression of a subset of drug transporters; knockout of Mrp1/Abcc1 enhances drug sensitivity. Tamoxifen administration to Rosa26CreERT2;mT/mG mice visually highlights the drug-resistant intestinal stromal compartment and identifies small populations of drug-resistant cells in lung, kidney, and pancreatic islets. Xenobiotic resistance of the Wnt-producing myofibroblasts can protect the intestinal stem cell niche in the face of an unpredictable environment.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleIntrinsic Xenobiotic Resistance of the Intestinal Stem Cell Nicheen_US
dc.typeJournal articleen_US
dc.creator.authorChee, Yuemin Celina
dc.creator.authorPahnke, Jens
dc.creator.authorBunte, Ralph
dc.creator.authorAdsool, Vikrant A
dc.creator.authorMadan, Babita
dc.creator.authorVirshup, David M
cristin.unitcode185,53,18,13
cristin.unitnameAvdeling for patologi
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2
dc.identifier.cristin1655231
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Developmental Cell&rft.volume=46&rft.spage=681&rft.date=2018
dc.identifier.jtitleDevelopmental Cell
dc.identifier.volume46
dc.identifier.issue6
dc.identifier.startpage681
dc.identifier.endpage695.e5
dc.identifier.doihttps://doi.org/10.1016/j.devcel.2018.07.023
dc.identifier.urnURN:NBN:no-74281
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1534-5807
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/71163/1/Chee_Jens%2BPahnke_DEVELOPMENTAL-CELL-D-17-00887_R3_Cristin-post%2B1655231.pdf
dc.type.versionAcceptedVersion
dc.relation.projectEU/643417
dc.relation.projectNFR/260786
dc.relation.projectHSØ/2016062
dc.relation.projectNFR/251290


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International